You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GBM

Showing 1 - 25 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)

Recruiting
  • GBM
  • Postoperative radiotherapy for SVZ
  • Nanjing, Jiangsu, China
    Lining Guo
Oct 14, 2023

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors

Recruiting
  • Glioblastoma Multiforme
  • Surgical removal of the GBM tumor
  • d4-NAM infusion
  • Orlando, Florida
    AdventHealth Translational Research Institute
Sep 20, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

Recruiting
  • Glioma, Malignant
  • +6 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 13, 2023

Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)

Not yet recruiting
  • Glioblastoma
  • Amyvid, Intravenous Solution
  • Bayamon, Puerto Rico
  • +1 more
Apr 18, 2023

Glioblastoma Trial (PEP-CMV vaccine)

Not yet recruiting
  • Glioblastoma
  • PEP-CMV vaccine
  • (no location specified)
Nov 9, 2023

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Glioblastoma Trial (Tofacitinib 5 MG)

Recruiting
  • Glioblastoma
  • Tofacitinib 10mg
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 3, 2023

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Glioblastoma Trial in Boston (ITI-1001)

Not yet recruiting
  • Glioblastoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 13, 2023

Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

Not yet recruiting
  • Recurrent Glioblastoma
  • Sintilimab plus Bevacizumab and Temozolomide
  • (no location specified)
Nov 27, 2022

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days

Recruiting
  • Glioblastoma, Adult
  • Pembrolizumab at 7 days prior
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Glioblastoma Trial run by the NCI (drug, biological, other)

Completed
  • Glioblastoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 23, 2022

Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

Not yet recruiting
  • Glioma, Malignant
  • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
  • Hiltonol
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023

Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

Recruiting
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2022

Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)

Recruiting
  • Recurrent GBM
  • SONALA-001 (ALA) and Exablate device
  • Phoenix, Arizona
  • +2 more
Jan 6, 2023

Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

Active, not recruiting
  • Glioblastoma Multiforme
  • VBI-1901
  • +2 more
  • Los Angeles, California
  • +3 more
Jun 27, 2022

Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome Trial in

Recruiting
  • Anti-Glomerular Basement Membrane Disease
  • +3 more
  • Chapel Hill, North Carolina
    UNC Kidney Center/Division of Nephrology & Hypertension
Dec 23, 2022

Gut microBIOME in Glioblastoma Patients Receiving

Not yet recruiting
  • Glioblastoma, IDH-wildtype
    • (no location specified)
    Apr 5, 2022

    Glioblastoma Multiforme Trial in United States (Nativis Voyager)

    Completed
    • Glioblastoma Multiforme
    • Nativis Voyager
    • Tucson, Arizona
    • +6 more
    Jan 31, 2023

    Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

    Not yet recruiting
    • Glioblastoma Multiforme of Brain
    • TVI-Brain-1
    • +3 more
    • (no location specified)
    Jan 13, 2023

    Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))

    Recruiting
    • Glioblastoma (GBM)
    • Advanced diffusion-weighted MRI (ADW-MRI)
    • Basel, Switzerland
      University Hospital Basel
    Jun 21, 2023